Emerging CAR-T Cell Therapies for T Cell Malignancies: Innovations, Challenges, and Future Directions
Continued efforts to identify highly specific target antigens, optimize manufacturing processes, enhance safety, and integrate CAR-T therapy with complementary immunotherapeutic approaches are expected to improve clinical outcomes and broaden the application of CAR-T therapy to T-cell malignancies and potentially other...